Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2011, Article ID 278963, 11 pages
http://dx.doi.org/10.1155/2011/278963
Research Article

Osmolarity and Glucose Differentially Regulate Aldose Reductase Activity in Cultured Mouse Podocytes

1Department of Pathophysiology, Medical University of Gdansk, 80-211 Gdansk, Poland
2Laboratory of Cellular and Molecular Nephrology, Mossakowski Medical Research Centre, Polish Academy of Sciences, 02-106 Warsaw/Gdansk, Poland
3Department of Clinical Immunology and Transplantation, Medical University of Gdansk, 80-210 Gdansk, Poland

Received 14 July 2011; Revised 5 September 2011; Accepted 23 September 2011

Academic Editor: Theodore W. Kurtz

Copyright © 2011 Barbara Lewko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. S. Kolb, L. A. Hunsaker, and D. L. Vander Jagt, “Aldose reductase-catalyzed reduction of acrolein: implications in cyclophosphamide toxicity,” Molecular Pharmacology, vol. 45, no. 4, pp. 797–801, 1994. View at Google Scholar · View at Scopus
  2. C. Yabe-Nishimura, “Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications,” Pharmacological Reviews, vol. 50, no. 1, pp. 21–33, 1998. View at Google Scholar · View at Scopus
  3. J. M. Petrash, “All in the family: aldose reductase and closely related aldo-keto reductases,” Cellular and Molecular Life Sciences, vol. 61, no. 7-8, pp. 737–749, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Maekawa, T. Tanimoto, and S. Okada, “Gene expression of enzymes comprising the polyol pathway in various rat tissues determined by the competitive RT-PCR method,” Japanese Journal of Pharmacology, vol. 88, no. 1, pp. 123–126, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. S. K. Srivastava, K. V. Ramana, and A. Bhatnagar, “Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options,” Endocrine Reviews, vol. 26, no. 3, pp. 380–392, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. D. L. Vander Jagt, N. S. Kolb, T. J. Vander Jagt et al., “Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate,” Biochimica et Biophysica Acta, vol. 1249, no. 2, pp. 117–126, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. S. E. Spycher, S. Tabataba-Vakili, V. B. O'Donnell, L. Palomba, and A. Azzi, “Aldose reductase induction:a novel response to oxidative stress of smooth muscle cells,” FASEB Journal, vol. 11, no. 2, pp. 181–188, 1997. View at Google Scholar · View at Scopus
  8. K. V. Ramana, B. L. Dixit, S. Srivastava, G. K. Balendiran, S. K. Srivastava, and A. Bhatnagar, “Selective recognition of glutathiolated aldehydes by aldose reductase,” Biochemistry, vol. 39, no. 40, pp. 12172–12180, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Moriyama, A. Garcia-Perez, and M. B. Burg, “Osmotic regulation of aldose reductase protein synthesis in renal medullary cells,” Journal of Biological Chemistry, vol. 264, no. 28, pp. 16810–16814, 1989. View at Google Scholar · View at Scopus
  10. J. Steffgen, K. Kampfer, C. Grupp, C. Langenberg, G. A. Müller, and R. W. Grunewald, “Osmoregulation of aldose reductase and sorbitol dehydrogenase in cultivated interstitial cells of rat renal inner medulla,” Nephrology Dialysis Transplantation, vol. 18, no. 11, pp. 2255–2261, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. K. V. Ramana, B. Friedrich, S. Srivastava, A. Bhatnagar, and S. K. Srivastava, “Activation of nulcear factor-κB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase,” Diabetes, vol. 53, no. 11, pp. 2910–2920, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. G. L. King, “The role of inflammatory cytokines in diabetes and its complications,” Journal of Periodontology, vol. 79, no. 8, pp. 1527–1534, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Zopf, J. Flamig, H. Schmid et al., “Localization of the polyol pathway in the human kidney,” Histology and Histopathology, vol. 24, pp. 447–455, 2009. View at Google Scholar
  14. R. Kikkawa, K. Umemura, M. Haneda et al., “Identification and characterization of aldose reductase in cultured rat mesangial cells,” Diabetes, vol. 41, no. 9, pp. 1165–1171, 1992. View at Google Scholar · View at Scopus
  15. Q. Dan, R. L. Wong, S. Yin, S. K. Chung, S. S. Chung, and K. S. Lam, “Interaction between the polyol pathway and non-enzymatic glycation on mesangial cell gene expression,” Nephron Experimental Nephrology, vol. 98, no. 3, pp. e89–e99, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Prunotto, M. L. Carnevali, G. Candiano et al., “Autoimmunity in membranous nephropathy targets aldose reductase and SOD2,” Journal of the American Society of Nephrology, vol. 21, no. 3, pp. 507–519, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Kasajima, S. Yamagishi, S. Sugai, N. Yagihashi, and S. Yagihashi, “Enhanced in situ expression of aldose reductase in peripheral nerve and renal glomeruli in diabetic patients,” Virchows Archiv, vol. 439, no. 1, pp. 46–54, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Liu, P. Liu, S. Tao et al., “Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose,” Archives of Biochemistry and Biophysics, vol. 475, no. 2, pp. 128–134, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. H. E. Harrison, D. Stribling, F. M. Armstrong, and C. Michael Perkins, “Aldose reductase in the etiology of diabetic complications: i. introduction,” Journal of Diabetic Complications, vol. 3, no. 1, pp. 6–11, 1989. View at Google Scholar · View at Scopus
  20. S. M. Donnelly, X. P. Zhou, J. T. Huang, and C. I. Whiteside, “Prevention of early glomerulopathy with tolrestat in the streptozotocin-induced diabetic rat,” Biochemistry and Cell Biology, vol. 74, no. 3, pp. 355–362, 1996. View at Google Scholar · View at Scopus
  21. J. K. Sung, J. H. Koh, M. Y. Lee et al., “Aldose reductase inhibitor ameliorates renal vascular endothelial growth factor expression in streptozotocin-induced diabetic rats,” Yonsei Medical Journal, vol. 51, no. 3, pp. 385–391, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Stribling, F. M. Armstrong, and H. E. Harrison, “Aldose reductase in the etiology of diabetic complications: 2. Nephropathy,” Journal of Diabetic Complications, vol. 3, no. 2, pp. 70–76, 1989. View at Google Scholar · View at Scopus
  23. R. C. Wiggins, “The spectrum of podocytopathies: a unifying view of glomerular diseases,” Kidney International, vol. 71, no. 12, pp. 1205–1214, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Kobayashi, J. Reiser, K. Schwarz, T. Sakai, W. Kriz, and P. Mundel, “Process formation of podocytes: morphogenetic activity of microtubules and regulation by protein serine/threonine phosphatase PP2A,” Histochemistry and Cell Biology, vol. 115, no. 3, pp. 255–266, 2001. View at Google Scholar · View at Scopus
  25. Y. Fujii, J. Khoshnoodi, H. Takenaka et al., “The effect of dexamethasone on defective nephrin transport caused by ER stress: a potential mechanism for the therapeutic action of glucocorticoids in the acquired glomerular diseases,” Kidney International, vol. 69, no. 8, pp. 1350–1359, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Google Scholar · View at Scopus
  27. S. P. Wolff and M. J. Crabbe, “Low apparent aldose reductase activity produced by monosaccharide autoxidation,” Biochemical Journal, vol. 226, no. 3, pp. 625–630, 1985. View at Google Scholar · View at Scopus
  28. N. Endlich, E. Schordan, C. D. Cohen et al., “European Renal c DNABC: palladin is a dynamic actin-associated protein in podocytes,” Kidney International, vol. 75, pp. 214–226, 2009. View at Google Scholar
  29. J. Biederman, J. Yee, and P. Cortes, “Validation of internal control genes for gene expression analysis in diabetic glomerulosclerosis,” Kidney International, vol. 66, no. 6, pp. 2308–2314, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. D. N. Henry, R. N. Frank, S. R. Hootman, S. E. Rood, C. W. Heilig, and J. V. Busik, “Glucose-specific regulation of aldose reductase in human retinal pigment epithelial cells in vitro,” Investigative Ophthalmology and Visual Science, vol. 41, no. 6, pp. 1554–1560, 2000. View at Google Scholar · View at Scopus
  31. A. D. Hodgkinson, K. L. Søndergaard, B. Yang, D. F. Cross, B. A. Millward, and A. G. Demaine, “Aldose reductase expression is induced by hyperglycemia in diabetic nephropathy,” Kidney International, vol. 60, no. 1, pp. 211–218, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. L. T. Chylack Jr., W. Tung, and R. Harding, “Sorbitol production in the lens: a means of counteracting glucose-derived osmotic stress,” Ophthalmic Research, vol. 18, no. 5, pp. 313–320, 1986. View at Google Scholar · View at Scopus
  33. T. Nishinaka and C. Yabe-Nishimura, “EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress,” Free Radical Biology and Medicine, vol. 31, no. 2, pp. 205–216, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Kaiserova, S. Srivastava, J. D. Hoetker et al., “Redox activation of aldose reductase in the ischemic heart,” Journal of Biological Chemistry, vol. 281, no. 22, pp. 15110–15120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Schordan, E. Schordan, N. Endlich et al., “Alterations of the podocyte proteome in response to high glucose concentrations,” Proteomics, vol. 9, no. 19, pp. 4519–4528, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Ohtaka, M. Tawata, Y. Hosaka, and T. Onaya, “Glucose modulation of aldose reductase mRNA expression and its activity in cultured calf pulmonary artery endothelial cells,” Diabetologia, vol. 35, no. 8, pp. 730–734, 1992. View at Google Scholar · View at Scopus
  37. R. W. Grunewald, A. Eckstein, C. H. Reisse, and G. A. Müller, “Characterization of aldose reductase from the thick ascending limb of Henle's loop of rabbit kidney,” Nephron, vol. 89, no. 1, pp. 73–81, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. P. F. Kador, G. Sun, V. K. Rait, L. Rodriguez, Y. Ma, and K. Sugiyama, “Intrinsic inhibition of aldose reductase,” Journal of Ocular Pharmacology and Therapeutics, vol. 17, no. 4, pp. 373–381, 2001. View at Google Scholar · View at Scopus
  39. D. A. Allen, M. M. Yaqoob, and S. M. Harwood, “Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications,” The Journal of Nutritional Biochemistry, vol. 16, no. 12, pp. 705–713, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Susztak, A. C. Raff, M. Schiffer, and E. P. Böttinger, “Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy,” Diabetes, vol. 55, no. 1, pp. 225–233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. A. P. Rolo and C. M. Palmeira, “Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress,” Toxicology and Applied Pharmacology, vol. 212, no. 2, pp. 167–178, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Varma, S. Q. Liu, M. West et al., “Protein kinase C-dependent phosphorylation and mitochondrial translocation of aldose reductase,” FEBS Letters, vol. 534, no. 1–3, pp. 175–179, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. A. P. Sanchez and K. Sharma, “Transcription factors in the pathogenesis of diabetic nephropathy,” Expert Reviews in Molecular Medicine, vol. 11, p. e13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Hoshi, K. I. Nomoto, J. Kuromitsu, S. Tomari, and M. Nagata, “High glucose induced VEGF expression via PKC and ERK in glomerular podocytes,” Biochemical and Biophysical Research Communications, vol. 290, no. 1, pp. 177–184, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. I. Tossidou, B. Teng, J. Menne et al., “Podocytic PKC-α is regulated in murine and human diabetes and mediates nephrin endocytosis,” PLoS ONE, vol. 5, no. 4, Article ID e10185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. J. M. Petrash, M. Flath, D. Sens, and J. Bylander, “Effects of osmotic stress and hyperglycemia on aldose reductase gene expression in human renal proximal tubule cells,” Biochemical and Biophysical Research Communications, vol. 187, no. 1, pp. 201–208, 1992. View at Google Scholar · View at Scopus
  47. S. Srivastava, B. L. Dixit, K. V. Ramana et al., “Structural and kinetic modifications of aldose reductase by S-nitrosothiols,” Biochemical Journal, vol. 358, no. 1, pp. 111–118, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Del Corso, M. Cappiello, and U. Mura, “From a dull enzyme to something else: facts and perspectives regarding aldose reductase,” Current Medicinal Chemistry, vol. 15, no. 15, pp. 1452–1461, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. A. A. Eid, Y. Gorin, B. M. Fagg et al., “Mechanisms of podocyte injury in diabetes: role of cytochrome p450 and NADPH oxidases,” Diabetes, vol. 58, no. 5, pp. 1201–1211, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Piwkowska, D. Rogacka, M. Jankowski et al., “Metformin induces suppression of NAD(P)H oxidase activity in podocytes,” Biochemical and Biophysical Research Communications, vol. 393, pp. 268–273, 2010. View at Google Scholar
  51. S. P. Baba, K. Wetzelberger, J. D. Hoetker, and A. Bhatnagar, “Posttranslational glutathiolation of aldose reductase (AKR1B1): a possible mechanism of protein recovery from S-nitrosylation,” Chemico-Biological Interactions, vol. 178, no. 1–3, pp. 250–258, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Trachtman, S. Futterweit, and D. Crimmins, “High glucose inhibits nitric oxide production in cultured rat mesangial cells,” Journal of the American Society of Nephrology, vol. 8, no. 8, pp. 1276–1282, 1997. View at Google Scholar · View at Scopus
  53. T. Nakagawa, K. Tanabe, B. P. Croker et al., “Endothelial dysfunction as a potential contributor in diabetic nephropathy,” Nature Reviews Nephrology, vol. 7, no. 1, pp. 36–44, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Jarry, K. Renaudin, M. G. Denis et al., “Expression of NOS1 and soluble guanylyl cyclase by human kidney epithelial cells: morphological evidence for an autocrine/paracrine action of nitric oxide,” Kidney International, vol. 64, no. 1, pp. 170–180, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Q. Qiu, R. Sinniah, and S. I. H. Hsu, “Downregulation of Bcl-2 by podocytes is associated with progressive glomerular injury and clinical indices of poor renal prognosis in human IgA nephropathy,” Journal of the American Society of Nephrology, vol. 15, no. 1, pp. 79–90, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. D. N. Henry, M. Del Monte, D. A. Greene, and P. D. Killen, “Altered aldose reductase gene regulation in cultured human retinal pigment epithelial cells,” Journal of Clinical Investigation, vol. 92, no. 2, pp. 617–623, 1993. View at Google Scholar · View at Scopus
  57. K. Aida, M. Tawata, Y. Ikegishi, and T. Onaya, “Induction of rat aldose reductase gene transcription is mediated through the cis-element, osmotic response element (ORE): increased synthesis and/or activation by phosphorylation of ORE-binding protein is a key step,” Endocrinology, vol. 140, no. 2, pp. 609–617, 1999. View at Publisher · View at Google Scholar · View at Scopus
  58. B. Ruepp, K. M. Bohren, and K. H. Gabbay, “Characterization of the osmotic response element of the human aldose reductase gene promoter,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 16, pp. 8624–8629, 1996. View at Publisher · View at Google Scholar · View at Scopus
  59. P. Russell, T. Yamada, and L. O. Merola, “Induction of the enzyme aldose reductase in a lens epithelial cell line from a transgenic mouse,” Archives of Biochemistry and Biophysics, vol. 276, no. 1, pp. 259–264, 1990. View at Publisher · View at Google Scholar · View at Scopus
  60. A. S. Galvez, J. A. Ulloa, M. Chiong et al., “Aldose reductase induced by hyperosmotic stress mediates cardiomyocyte apoptosis,” Journal of Biological Chemistry, vol. 278, no. 40, pp. 38484–38494, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. J. M. Petrash, T. M. Harter, C. S. Devine et al., “Involvement of cysteine residues in catalysis and inhibition of human aldose reductase. Site-directed mutagenesis of Cys-80, -298, and -303,” Journal of Biological Chemistry, vol. 267, no. 34, pp. 24833–24840, 1992. View at Google Scholar · View at Scopus
  62. K. Maekawa, T. Tanimoto, S. Okada, T. Suzuki, and C. Yabe-Nishimura, “Expression of aldose reductase and sorbitol dehydrogenase genes in Schwann cells isolated from rat: effects of high glucose and osmotic stress,” Molecular Brain Research, vol. 87, no. 2, pp. 251–256, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Yabe-Nishimura, T. Nishinaka, K. Iwata, and H. G. Seo, “Up-regulation of aldose reductase by the substrate, methylglyoxal,” Chemico-Biological Interactions, vol. 143-144, pp. 317–323, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. C. Hwang, S. Sato, J.-Y. Tsai et al., “Aldose reductase activation is a key component of myocardial response to ischemia,” The FASEB Journal, vol. 16, no. 2, pp. 243–245, 2002. View at Google Scholar · View at Scopus
  65. K. Iwata, T. Nishinaka, K. Matsuno et al., “The activity of aldose reductase is elevated in diabetic mouse heart,” Journal of Pharmacological Sciences, vol. 103, no. 4, pp. 408–416, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. S. K. Srivastava, N. H. Ansari, G. A. Hair et al., “Hyperglycemia-induced activation of human erythrocyte aldose reductase and alterations in kinetics properties,” Biochimica et Biophysica Acta, vol. 870, no. 2, pp. 302–311, 1986. View at Google Scholar · View at Scopus
  67. D. L. Vander Jagt and L. A. Hunsaker, “Substrate specificity of reduced and oxidized forms of human aldose reductase,” Advances in Experimental Medicine and Biology, vol. 328, pp. 279–288, 1993. View at Google Scholar · View at Scopus
  68. D. L. Vander Jagt, B. Robinson, K. K. Taylor, and L. A. Hunsaker, “Aldose reductase from human skeletal and heart muscle. Interconvertible forms related by thiol-disulfide exchange,” Journal of Biological Chemistry, vol. 265, no. 34, pp. 20982–20987, 1990. View at Google Scholar · View at Scopus
  69. C. E. Grimshaw and C. J. Lai, “Oxidized aldose reductase: in vivo factor, not in vitro artifact,” Archives of Biochemistry and Biophysics, vol. 327, no. 1, pp. 89–97, 1996. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Burdo, R. Dargusch, and D. Schubert, “Distribution of the cystine/glutamate antiporter system xc- in the brain, kidney, and duodenum,” Journal of Histochemistry and Cytochemistry, vol. 54, no. 5, pp. 549–557, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. G. J. McBean and J. Flynn, “Molecular mechanisms of cystine transport,” Biochemical Society Transactions, vol. 29, no. 6, pp. 717–722, 2001. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Cappiello, M. Voltarelli, I. Cecconi et al., “Specifically targeted modification of human aldose reductase by physiological disulfides,” Journal of Biological Chemistry, vol. 271, no. 52, pp. 33539–33544, 1996. View at Publisher · View at Google Scholar · View at Scopus
  73. J. Gloy, S. Reitinger, K. G. Fischer et al., “Amino acid transport in podocytes,” American Journal of Physiology, vol. 278, no. 6, pp. F999–F1005, 2000. View at Google Scholar · View at Scopus
  74. L. Giardino, S. Armelloni, A. Corbelli et al., “Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier,” Journal of the American Society of Nephrology, vol. 20, no. 9, pp. 1929–1940, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. M. P. Rastaldi, S. Armelloni, S. Berra et al., “Glomerular podocytes contain neuron-like functional synaptic vesicles,” The FASEB Journal, vol. 20, no. 7, pp. 976–978, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. E. M. Rigney, O. Phillips, and T. J. Mantle, “Some physical and immunological properties of ox kidney biliverdin reductase,” Biochemical Journal, vol. 255, no. 2, pp. 431–435, 1988. View at Google Scholar · View at Scopus
  77. M. A. Ludvigson and R. L. Sorenson, “Immunohistochemical localization of aldose reductase. II. Rat eye and kidney,” Diabetes, vol. 29, no. 6, pp. 450–459, 1980. View at Google Scholar · View at Scopus
  78. S. H. Han, S. Yang, D. S. Jung et al., “Gene expression patterns in glucose-stimulated podocytes,” Biochemical and Biophysical Research Communications, vol. 370, no. 3, pp. 514–518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. J. Müller-Deile, K. Worthmann, M. Saleem, I. Tossidou, H. Haller, and M. Schiffer, “The balance of autocrine VEGF-A and VEGF-C determines podocyte survival,” American Journal of Physiology, vol. 297, no. 6, pp. F1656–F1667, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. K. N. Lai, J. C. Leung, L. Y. Chan et al., “Activation of podocytes by mesangial-derived TNF-α: glomerulo-podocytic communication in IgA nephropathy,” American Journal of Physiology, vol. 294, no. 4, pp. F945–F955, 2008. View at Publisher · View at Google Scholar · View at Scopus